These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
712 related items for PubMed ID: 27879486
1. Prospective interventional study of tenofovir in pregnancy to prevent vertical transmission of hepatitis B in highly viremic women. Sellier PO, Maylin S, Berçot B, Chopin D, Lopes A, Simoneau G, Evans J, Delcey V, Bénifla JL, Simon F, Bergmann JF. Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):259-263. PubMed ID: 27879486 [Abstract] [Full Text] [Related]
2. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers. Chang KC, Chang MH, Lee CN, Chang CH, Wu JF, Ni YH, Wen WH, Shyu MK, Lai MW, Chen SM, Hu JJ, Lin HH, Hsu JJ, Mu SC, Lin YC, Liu CJ, Chen DS, Lin LH, Chen HL, Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463 [Abstract] [Full Text] [Related]
3. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, Gulsun S, Barcin T, Kalkanli S, Dal MS, Ayaz C. World J Gastroenterol; 2013 Dec 28; 19(48):9377-82. PubMed ID: 24409065 [Abstract] [Full Text] [Related]
4. Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study. Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF. Eur J Gastroenterol Hepatol; 2016 Mar 28; 28(3):328-32. PubMed ID: 26709883 [Abstract] [Full Text] [Related]
5. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region. Samadi Kochaksaraei G, Castillo E, Osman M, Simmonds K, Scott AN, Oshiomogho JI, Lee SS, Myers RP, Martin SR, Coffin CS. J Viral Hepat; 2016 Jan 28; 23(1):15-22. PubMed ID: 26192022 [Abstract] [Full Text] [Related]
6. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study. Wu Q, Huang H, Sun X, Pan M, He Y, Tan S, Zeng Y, Li L, Deng G, Yan Z, He D, Li J, Wang Y. Clin Gastroenterol Hepatol; 2015 Jun 28; 13(6):1170-6. PubMed ID: 25251571 [Abstract] [Full Text] [Related]
7. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N. N Engl J Med; 2018 Mar 08; 378(10):911-923. PubMed ID: 29514030 [Abstract] [Full Text] [Related]
8. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV. Wang J, Liu J, Qi C, Yan T, Cao F, Jin L, He Y, Yang Y, Zhang S, Chen T, Zhao Y. Antivir Ther; 2015 Mar 08; 20(7):681-7. PubMed ID: 26215771 [Abstract] [Full Text] [Related]
9. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up. Virine B, Osiowy C, Gao S, Wang T, Castillo E, Martin SR, Lee SS, Simmonds K, van Marle G, Coffin CS. PLoS One; 2015 Mar 08; 10(10):e0140070. PubMed ID: 26474400 [Abstract] [Full Text] [Related]
10. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, China Study Group for the Mother-to-Child Transmission of Hepatitis B. N Engl J Med; 2016 Jun 16; 374(24):2324-34. PubMed ID: 27305192 [Abstract] [Full Text] [Related]
11. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission]. Yin YZ, Zhou J, Zhang PZ, Hou HY. Zhonghua Gan Zang Bing Za Zhi; 2013 Feb 16; 21(2):105-10. PubMed ID: 23663881 [Abstract] [Full Text] [Related]
12. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N. BMC Infect Dis; 2016 Aug 09; 16():393. PubMed ID: 27506549 [Abstract] [Full Text] [Related]
13. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province]. Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX. Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789 [Abstract] [Full Text] [Related]
14. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus. Zhu B, Lv X, Zhao Z, Chen L, Chen X, Li C, Li S, Dai E. Medicine (Baltimore); 2021 Nov 05; 100(44):e27695. PubMed ID: 34871254 [Abstract] [Full Text] [Related]
15. Tenofovir rescue therapy in pregnant females with chronic hepatitis B. Hu YH, Liu M, Yi W, Cao YJ, Cai HD. World J Gastroenterol; 2015 Feb 28; 21(8):2504-9. PubMed ID: 25741161 [Abstract] [Full Text] [Related]
16. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Chen HL, Lee CN, Chang CH, Ni YH, Shyu MK, Chen SM, Hu JJ, Lin HH, Zhao LL, Mu SC, Lai MW, Lee CL, Lin HM, Tsai MS, Hsu JJ, Chen DS, Chan KA, Chang MH, Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study), Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV PreMIT Study. Hepatology; 2015 Aug 28; 62(2):375-86. PubMed ID: 25851052 [Abstract] [Full Text] [Related]
17. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX. J Hepatol; 2011 Dec 28; 55(6):1215-21. PubMed ID: 21703206 [Abstract] [Full Text] [Related]
18. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, Silverman NS. Am J Obstet Gynecol; 2016 Jan 28; 214(1):6-14. PubMed ID: 26454123 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk. Samadi Kochaksaraei G, Congly SE, Matwiy T, Castillo E, Martin SR, Charlton CL, Coffin CS. Liver Int; 2016 Nov 28; 36(11):1604-1610. PubMed ID: 27059287 [Abstract] [Full Text] [Related]
20. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate. Chang HL, Wen WH, Lee CN, Chiu YE, Liu CJ, Chang MH, Lin LH, Chen HL. J Viral Hepat; 2022 Feb 28; 29(2):107-114. PubMed ID: 34724288 [Abstract] [Full Text] [Related] Page: [Next] [New Search]